Flulaval Quadrivalent

Product NDC
19515-909
11-digit product format
195150909
Labeler code
19515
Product ID
19515-909_c8c51d20-592c-4b20-a67a-2a9961931e33
Type
VACCINE
Nonproprietary name
influenza virus vaccine
Dosage form
SUSPENSION
Route
INTRAMUSCULAR
Labeler
ID Biomedical Corporation of Quebec
Application
BLA125163
Marketing category
BLA
Marketing start
2018-06-29
Marketing end
2019-06-30
Substance
INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180 (H1N1) ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/SINGAPORE/INFIMH-16-0019/2016 IVR-186 (H3N2) ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MARYLAND/15/2016 BX-69A ANTIGEN (UV, FORMALDEHYDE INACTIVATED)
Active strength
15 ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL
NDC exclude flag
No
Listing certified through
0000-00-00
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct19515-909DDiscontinued by firm2026-07-31
excluded packagepackage19515-90919515-909-52DDiscontinued by firm2026-07-31

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
19515-909-41ML - Milliliter19515-90940d5c54f-0efc-479c-8de4-7cda92b3e52b12018-08-13
19515-909-52ML - Milliliter19515-9098d9f6012-7466-44a1-87a7-e6439ae29a0812018-08-13

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125163Flulaval, Flulaval QuadrivalentInfluenza Vaccine351(a)Rx2026-06-01